Insights
Little Green Pharma (ASX:LGP) receives manufacturing permit
We have been granted a new manufacturing permit from the Office of Drug Control. Read more...
May 2020
27 Oct 2020
Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia. This license means:
The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy.
Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets.
The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.
Insights
We have been granted a new manufacturing permit from the Office of Drug Control. Read more...
May 2020
Insights
Australia's latest listed medicinal cannabis company has launched onto the market with a bang, scoring a major UK distribution deal the night before landing.
Feb 2020
Company news
Little Green Pharma have sponsored a new digital platform, GreenChoices to provide both medical practitioners and patients with meaningful research and education, with the aim of assisting them make informed choices about medical cannabis as a possible treatment option.
Aug 2018